| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2023 | Aug 16, 2023 | Taysha Gene Therapies, Inc. | CEO | Buy | 97.5 | +444,444 | 40.69% | ✗ | $400K |
| May 20, 2021 | May 24, 2021 | Taysha Gene Therapies, Inc. | Director | Buy | 56.3 | +1,170 | 0.11% | ✗ | $26.1K |